“driving with dementia”的搜索结果，显示 61-70 项，共有 355 项
-
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...
-
ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...
-
ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...
-
ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...
-
ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...
-
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...
-
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013).
-
John A. Lucas, Ph.D. Psychologist. Jacksonville, FL. 擅长领域：. Neuropsychological assessment, Movement disorder, Dementia, Alzheimer's disease, Memory loss ...
-
AskMayoExpert. Alzheimer disease dementia. Mayo Clinic; 2023. What is ... Podcast: How to prevent dementia · 今天踊跃捐赠，为明天寻找阿尔茨海默病治愈 ...
-
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...